These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12415186)

  • 1. Alterations of cell cycle-regulatory genes in prostate cancer.
    Fernández PL; Hernández L; Farré X; Campo E; Cardesa A
    Pathobiology; 2002; 70(1):1-10. PubMed ID: 12415186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers.
    Gotoh A; Kao C; Ko SC; Hamada K; Liu TJ; Chung LW
    J Urol; 1997 Aug; 158(2):636-41. PubMed ID: 9224383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances on molecular pathology of prostate carcinoma].
    Niu HL; Tao Y
    Ai Zheng; 2003 May; 22(5):552-6. PubMed ID: 12753724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
    Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
    Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular analysis for prostate cancer].
    Ueda T; Suzuki H; Ichikawa T
    Nihon Rinsho; 2005 Feb; 63(2):213-7. PubMed ID: 15714968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic research in prostate cancer: molecular biology.
    Effert PJ; Strohmeyer TG
    Acta Urol Belg; 1994 Apr; 62(1):15-21. PubMed ID: 8197925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
    Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
    Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor genes in prostatic oncogenesis.
    Bookstein R
    J Cell Biochem Suppl; 1994; 19():217-23. PubMed ID: 7823594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
    Lim IK
    J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
    Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.
    Juang HH; Chung LC; Sung HC; Feng TH; Lee YH; Chang PL; Tsui KH
    Prostate; 2013 Oct; 73(14):1495-506. PubMed ID: 23794209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
    Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular changes associated with prostate cancer development.
    Ruijter E; Montironi R; van de Kaa C; Schalken J
    Anal Quant Cytol Histol; 2001 Feb; 23(1):67-88. PubMed ID: 11233745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of cell death regulation in the pathogenesis and treatment of prostate cancer.
    Bruckheimer EM; Gjertsen BT; McDonnell TJ
    Semin Oncol; 1999 Aug; 26(4):382-98. PubMed ID: 10482181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
    Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
    Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer.
    Hochhauser D
    Anticancer Drugs; 1997 Nov; 8(10):903-10. PubMed ID: 9436633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
    Wasielewski M; Hanifi-Moghaddam P; Hollestelle A; Merajver SD; van den Ouweland A; Klijn JG; Ethier SP; Schutte M
    Breast Cancer Res Treat; 2009 Jan; 113(2):285-91. PubMed ID: 18297428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.